Suppr超能文献

接受慢性抗凝治疗患者的机器人辅助根治性前列腺切除术:围手术期桥接治疗的作用

Robotic-assisted radical prostatectomy in patients receiving chronic anticoagulation therapy: role of perioperative bridging.

作者信息

Krane L Spencer, Laungani Rajesh, Satyanarayana Ramgopal, Kaul Sanjeev, Bhandari Mahendra, Peabody James O, Menon Mani

机构信息

Vattikuti Urology Institute, Henry Ford Health Systems, Detroit, Michigan 48202, USA.

出版信息

Urology. 2008 Dec;72(6):1351-5. doi: 10.1016/j.urology.2008.06.057.

Abstract

OBJECTIVES

Patients requiring chronic anticoagulation therapy (CAT) with warfarin require special attention perioperatively. We retrospectively reviewed our experience of treating patients requiring CAT who underwent robotic-assisted radical prostatectomy (RARP) to evaluate the role of perioperative bridging therapy.

METHODS

A total of 60 patients receiving cat with warfarin who underwent rarp were identified as having been treated using 1 of 2 protocols: protocol 1, the cessation of CAT 7 days before surgery and its resumption the evening of catheter removal (postoperative day 4-21); or protocol 2, warfarin substituted with perioperative subcutaneous low-molecular-weight heparin, with oral anticoagulation restarted after catheter removal. The decision to use perioperative bridging was made in conjunction with the patient's primary care physician. The peri- and postoperative parameters and complications were compared with a matched control group of 181 contemporary patients who underwent RARP but did not require CAT.

RESULTS

The most common indications for CAT were atrial fibrillation (58%) and recurrent deep vein thrombosis (22%). Compared with the control cohort, the patients with CAT had an increased operative time (189 vs 170 minutes, P = .005) and hospital stay (1.4 vs 1.1 days, P = .004). The estimated blood loss (123.9 vs 146.6 mL, P = .07) and 24-hour change in hemoglobin (2.2 vs 2.3 g/dL, P = .44) were similar. When comparing the 2 protocols, a significantly greater transfusion rate (23% vs 2%, P = .042) occurred with protocol 2, but no increase was seen in the complication or readmission rate. One nonfatal thromboembolic event occurred in 1 patient treated using protocol 1.

CONCLUSIONS

The results of our study have shown that RARP can be performed safely in patients requiring CAT, with and without bridging therapy. Patients in protocol 2 had greater transfusion rates, but this did not translate into increased complications or readmissions.

摘要

目的

需要使用华法林进行长期抗凝治疗(CAT)的患者在围手术期需要特别关注。我们回顾性分析了我们治疗接受机器人辅助根治性前列腺切除术(RARP)且需要CAT的患者的经验,以评估围手术期桥接治疗的作用。

方法

共有60例接受华法林CAT治疗并接受RARP的患者被确定采用以下两种方案之一进行治疗:方案1,术前7天停止CAT,导尿管拔除当晚(术后第4 - 21天)恢复使用;方案2,围手术期皮下注射低分子肝素替代华法林,导尿管拔除后重新开始口服抗凝治疗。围手术期桥接治疗的决定是与患者的初级保健医生共同做出的。将围手术期和术后参数及并发症与181例同期接受RARP但不需要CAT的匹配对照组患者进行比较。

结果

CAT最常见的适应证是房颤(58%)和复发性深静脉血栓形成(22%)。与对照组相比,接受CAT的患者手术时间延长(189分钟对170分钟,P = 0.005),住院时间延长(1.4天对1.1天,P = 0.004)。估计失血量(123.9毫升对146.6毫升,P = 0.07)和血红蛋白24小时变化(2.2克/分升对2.3克/分升,P = 0.44)相似。比较两种方案时,方案2的输血率显著更高(23%对2%,P = 0.042),但并发症或再入院率未见增加。在1例采用方案1治疗的患者中发生了1例非致命性血栓栓塞事件。

结论

我们的研究结果表明,无论是否进行桥接治疗,RARP均可在需要CAT的患者中安全进行。方案2的患者输血率更高,但这并未转化为并发症或再入院率的增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验